You are here

Merck KGaA

Merck KGaA investing €1B at headquarters site as part of 5-year work agreement

Fierce Pharma

Wed, 03/20/19 - 08:07 pm

Pfizer, Merck KGaA throw in the towel on another Bavencio PhIII as once bright hopes shrivel fast

Endpoints

Tue, 03/19/19 - 08:22 pm

Merck KGaA signs another AI deal

Pharmaforum

Fri, 03/15/19 - 09:19 am

artificial intelligence

Merck KGaA admits to ‘challenging’ 2018, as currencies hit sales

Pharmaforum

Thu, 03/7/19 - 10:03 am

After Tesaro buy, GSK wades deeper into cancer unveiling big immunotherapy deal with Germany's Merck

Endpoints

Tue, 02/5/19 - 09:52 am

Forget the suggestion box. Merck KGaA puts employee ideas on a TED stage

Fierce Pharma

Mon, 02/4/19 - 11:38 am

pharma employees

Merck KGaA signs China digital health deal with Tencent

Pharmaforum

Thu, 01/24/19 - 11:45 am

digital healthcare

artificial intelligence

Vertex sharpens focus on gene-editing in licensing deal with Merck KGaA

Endpoints

Thu, 01/24/19 - 11:39 am

Vertex Pharmaceuticals

Bavencio fails second ovarian cancer Phase III trial

BioCentury

Fri, 12/21/18 - 11:07 pm

Merck KGaA hands off its CAR-T R&D operations to Intrexon in $175M deal

Endpoints

Thu, 12/20/18 - 11:50 am

Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK

Fierce Pharma

Thu, 12/20/18 - 10:12 am

Merkel cell carcinoma

Merck KGaA links with AI firm to iron out side-effects during R&D

Pharmaforum

Mon, 12/10/18 - 09:56 am

artificial intelligence

drug development

Merck KGaA Partners With Startup for Image Tagging Software

Yahoo/Bloomberg

Wed, 12/5/18 - 09:49 am

artificial intelligence

Syntropy, a Merck KGaA – Palantir JV aiming to apply big data to cancer research

GoinPharma

Sun, 11/25/18 - 08:02 pm

Palantir Technologies

A Small Group of Pharma Companies Is Making the Bulk of Medicines Necessary for Developing Countries

BioSpace

Fri, 11/23/18 - 01:08 pm

developing countries

Merck KGaA Enters Field of Big Data With Joint Venture With Palantir Technologies

BioSpace

Tue, 11/20/18 - 11:50 am

Palantir Technologies

Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial

Marketwatch

Mon, 11/19/18 - 09:59 am

clinical trials

Immunicum Announces Collaboration with Merck KGaA and Pfizer to Evaluate Cell Therapy Treatment in Combination with Avelumab

CP Wire

Fri, 11/16/18 - 10:10 am

immuno-oncology

Merck KGaA’s bold new approach to cancer immunotherapy

Pharmaforum

Mon, 10/29/18 - 11:35 pm

cancer immunotherapy

Merck KGaA says might strike partnership deal this year

Yahoo/Reuters

Sun, 10/21/18 - 11:43 pm

Pages